Navigation Links
Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
Date:8/20/2007

Opening Bell Ceremony Marks Kendle's 10th Anniversary as Public Company

CINCINNATI, Aug. 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Chairman and CEO Candace Kendle, PharmD, will ring the opening bell at the NASDAQ Stock Market on Aug. 22, 2007, the company's 10th anniversary as a publicly-traded company. The Opening Bell ceremony will take place at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) in New York's Times Square and will be broadcast live on http://www.nasdaq.com and on the seven-story NASDAQ tower, the largest stationary video screen in the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

NASDAQ Opening Bell Ceremony - Webcam Instructions

To view the NASDAQ Opening Bell ceremony, go to http://www.kendle.com or http://www.nasdaq.com/about/marketsitetowervideo.asx. Please note:

-- Viewers must have Windows Media Player to view the webcam (Windows

Media Player is downloadable at no charge from

http://www.microsoft.com/windows/windowsmedia/default.aspx).

-- It is recommended viewers download the webcam at 9:15 a.m. so there is

time to troubleshoot in the event of technical difficulties

-- Prior to 9:20 a.m., the webcam will show the Tower; at 9:20 a.m. the

router will be switched and viewers will see inside the MarketSite

studio where the ceremony will take place

-- Viewers should not be alarmed that the webcam is fuzzy. Clarity is

dependent on Internet hook up.

NASDAQ Opening Bell Ceremony - Satellite Feed Information

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. For questions, please contact Jolene Libretto at NASDAQ at (646) 441-5220.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle

Copyright©2007 PR Newswire.

Related biology technology :

1. Merge files financial reports by market opening
2. NASDAQ will continue to list Merge
3. NASDAQ grants Merge more time for compliance
4. NASDAQ will continue to list Merge
5. No word on NASDAQ extension for Merge
6. NASDAQ puts Merge on notice again
7. Midwest life science stocks kept sizzling in Q2
8. Madisons PunchStock acquired by Getty Images
9. Midwest life science stocks sizzle in a tepid first quarter
10. Sonic Foundry completes $11.25M stock offer
11. Sonic Foundry sets $3.75 stock price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the "Nanobiotechnology ... ... separate comprehensive analytics for the US, Japan , ... and forecasts are provided for the period 2015 through 2022. Also, ... and analytics are derived from primary and secondary research. This report ...
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... a better treatment for triple negative breast cancer (TNBC), announced ... France program. The YEi Start in ... to help entrepreneurs grow their business in France ... American companies selected to complete an intensive one week immersion ...
(Date:2/16/2017)... -- Research and Markets has announced the ... report to their offering. ... The study scope ... plasmids, chassis organisms, synthetic cells, production systems), enabling technologies ... and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):